Page last updated: 2024-10-26

doxazosin and Obesity

doxazosin has been researched along with Obesity in 3 studies

Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
"We determined the effect of alpha-adrenergic blocking agent doxazosin on insulin resistance in 19 hypertensive patients (blood pressure [BP] >160/90 mmHg) with obesity (mean body mass index [BMI]: 26."9.10Effect of doxazosin on insulin resistance in hypertensive patients with obesity. ( Miyachi, Y; Ueshiba, H, 2003)
"We determined the effect of alpha-adrenergic blocking agent doxazosin on insulin resistance in 19 hypertensive patients (blood pressure [BP] >160/90 mmHg) with obesity (mean body mass index [BMI]: 26."5.10Effect of doxazosin on insulin resistance in hypertensive patients with obesity. ( Miyachi, Y; Ueshiba, H, 2003)
"Obesity was associated with increased prostate volume and lower urinary tract symptoms."1.37Comparison of the clinical efficacy of medical treatment of symptomatic benign prostatic hyperplasia between normal and obese patients. ( Chung, BH; Chung, MS; Lee, SH; Oh, CY; Park, KK; Yoo, SJ, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, SH1
Oh, CY1
Park, KK1
Chung, MS1
Yoo, SJ1
Chung, BH1
Ueshiba, H1
Miyachi, Y1
Wofford, MR1
Anderson, DC1
Brown, CA1
Jones, DW1
Miller, ME1
Hall, JE1

Trials

2 trials available for doxazosin and Obesity

ArticleYear
Effect of doxazosin on insulin resistance in hypertensive patients with obesity.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2003, Volume: 35, Issue:9

    Topics: Adipose Tissue; Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Doxazosin; Female; Humans

2003
Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects.
    American journal of hypertension, 2001, Volume: 14, Issue:7 Pt 1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure Monitorin

2001

Other Studies

1 other study available for doxazosin and Obesity

ArticleYear
Comparison of the clinical efficacy of medical treatment of symptomatic benign prostatic hyperplasia between normal and obese patients.
    Asian journal of andrology, 2011, Volume: 13, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Body Mass Index; Case-Control Studies; Doxazosin; Humans; M

2011